|
Re: Gilead GS-5829 Perspective
|
3
|
Zenith Epigenetics
|
Jul 21, 2017 02:54PM
|
|
Re: Gilead GS-5829 Perspective
|
3
|
Zenith Epigenetics
|
Jul 22, 2017 04:44PM
|
|
Congrats
|
6
|
Resverlogix Corp.
|
Jul 25, 2017 11:39AM
|
|
Re: Congrats
|
1
|
Resverlogix Corp.
|
Jul 25, 2017 12:42PM
|
|
Re: Resverlogix Files 2017 Year-End Disclosure Documents and Announces Plans to Host a Symposium at the European Society of Cardiology Congress 2017
|
5
|
Resverlogix Corp.
|
Jul 26, 2017 06:28PM
|
|
Share price - some thoughts
|
2
|
Resverlogix Corp.
|
Aug 01, 2017 11:00AM
|
|
Re: Share price - some thoughts
|
1
|
Resverlogix Corp.
|
Aug 01, 2017 03:07PM
|
|
Re: Debt and 28 August
|
2
|
Resverlogix Corp.
|
Aug 02, 2017 05:34PM
|
|
Re: Only 15 trading days left...
|
1
|
Resverlogix Corp.
|
Aug 03, 2017 02:41PM
|
|
Re: Q3 Events updated
|
2
|
Resverlogix Corp.
|
Aug 11, 2017 03:09PM
|
|
Re: Resverlogix (RVX) Reports Fiscal Year 2017 Results
|
5
|
Resverlogix Corp.
|
Aug 15, 2017 06:26PM
|
|
Re: Resverlogix (RVX) Reports Fiscal Year 2017 Results
|
1
|
Resverlogix Corp.
|
Aug 16, 2017 10:58AM
|
|
Re: A clinical future for RVX-2135 or just a pre-clinical tool
|
6
|
Zenith Epigenetics
|
Aug 16, 2017 03:33PM
|
|
Re: A clinical future for RVX-2135 or just a pre-clinical tool
|
3
|
Zenith Epigenetics
|
Aug 17, 2017 12:09PM
|
|
Re: A clinical future for RVX-2135 or just a pre-clinical tool
|
4
|
Zenith Epigenetics
|
Aug 17, 2017 07:13PM
|
|
Re: Courtesy
|
2
|
Resverlogix Corp.
|
Aug 19, 2017 01:17PM
|
|
Re: On the Stockhouse Board this morning
|
1
|
Resverlogix Corp.
|
Aug 21, 2017 12:50PM
|
|
Re: 96 hours
|
|
Resverlogix Corp.
|
Aug 22, 2017 12:18PM
|
|
Re: 96 hours
|
2
|
Resverlogix Corp.
|
Aug 22, 2017 07:55PM
|
|
Re: 96 hours
|
2
|
Resverlogix Corp.
|
Aug 23, 2017 05:00PM
|
